Gene Expression of Insulin-Like Growth Factors and Receptors in Neoplastic Prostate Tissues: Correlation with Clinico-pathological Parameters

REFERENCES

• Steiner M. S. Review of Peptide Growth Factors in Benign Prostatic Hyperplasia and Urological Malignancy. J. Urol. 1995; 153: 1085–1096
   PubMed Web of Science ®Google Scholar
• Krywicki R. F., Yee D. The Insulin-like Growth Factor Family of Ligands, Receptors and Binding Proteins. Breast Cancer Res. Treat. 1992; 22: 7–19
   PubMed Web of Science ®Google Scholar
• Kimura G., Kasuya J., Giannini S., Honda Y., Mohan S., Kawachi M., Akimoto M., Fujita Yamagushi Y. Insulin-like Growth Factor System Components in Human Pros-tatic Cancer Cell-Lines: LNCaP, DU145, PC-3. Int. J. Urol. 1996; 3: 39–46
   PubMedGoogle Scholar
• Pietrzkowski Z., Mulholland G., Gomella L., Jameson B. A., Wernicke D., Baserga R. Inhibition of Growth of Prostatic Cell Lines by Peptide Analogues of Insulin-like Growth Factors. Cancer Res. 1993; 33: 1102–1106
   Google Scholar
• Figueroa J. A., Lee A. V., Jackson J. G., Yee D. Proliferation of Cultured Human Prostate Cancer Cells Is Inhibited by Insulin-like Growth Factor Binding Protein-1: Evidence for an IGF-II Autocrine Growth Loop. J. Clin. Endocrinol. Metab. 1995; 80: 3476–3482
   PubMed Web of Science ®Google Scholar
• Angelloz-Nicoud P., Binoux M. Autocrine Regulation of Cell Proliferation by the Insulin-like Growth Factor (IGF) and IGF Binding Protein-3 Protease System in a Human Prostate Carcinoma Cell Line. Endocrinology 1995; 136: 5485–5492
   PubMed Web of Science ®Google Scholar
• Burfeind P., Chernicky C. L., Rininsland F., Ilan J. Antisense RNA to the Type I Insulin-like Growth Factor Receptor Suppresses Tumor Growth and Prevents Invasion by Rat Prostate Cancer Cells. In Vivo. Proc. Natl. Acad. Sci. 1996; 93: 7263–7268
   PubMed Web of Science ®Google Scholar
• Jarrard D. F., Bussemakers M. J.G., Bova G. S., Isaacs W. B. Regional Loss of Imprinting of the Insulin-like Growth Factor II Gene Occurs in Human Prostate Tissues. Clin. Cancer Res. 1995; 1: 1471–1478
   PubMed Web of Science ®Google Scholar
• Tennant M. K., Thrasher B., Twomey T. A., Drivdahl R. H., Birnbaum R. S., Plymate S. R. Protein and Messenger Ribonucleic Acid (mrna) for the Type I Insulin-like Growth Factor (IGF) Receptor Is Decreased and IGF-II Increased in Human Prostate Carcinoma Compared to Benign Prostate Epithelium. J. Clin. Endocrinol. Metab. 1996; 81: 3774–3782
   PubMed Web of Science ®Google Scholar
• Wheeler T. M., Lebovitz R. M. Fresh Tissue Harvest for Research from Prostatectomy Specimens. Prostate 1994; 25: 274–278
   PubMed Web of Science ®Google Scholar
• Cullen K. J., Smith H. S., Hill S., Rosen N., Lippman M. E. Growth Factor Messenger RNA Expression by Human Breast Fibroblasts from Benign and Malignant Lesions. Cancer Res. 1991; 51: 4978–4985
   PubMed Web of Science ®Google Scholar
• Cullen K. J., Yee D., Sly W. S., Perdue J., Hampton B., Lippman M. E., Rosen N. Insulin-like Growth Factor Receptor Expression and Function in Human Breast Cancer. Cancer Res. 1990; 50: 48–53
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single Step Method of RNA Isolation by Acid Guanidinium-Thiocyanate-Phenol-Chloroform Extraction. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Singer C., Rasmussen A., Smith H. S., Lippman M. E., Lynch H. T., Cullen K. J. Malignant Breast Epithelium Selects for Insulin-like Growth Factor II Expression in Breast Stroma: Evidence for Paracrine Function. Cancer Res. 1995; 55: 2448–2454
   PubMed Web of Science ®Google Scholar
• Yee D., Paik S., Lebovick G. S., Marcus R. R., Favoni R. E., Cullen K. J., Lippman M. E., Rosen N. Analysis of Insulin-like Growth Factor I Gene Expression in Malignancy: Evidence for a Paracrine Role in Human Breast Cancer. Mol. Endocrinol. 1989; 3: 509–517
   PubMed Web of Science ®Google Scholar
• Christofori G., Naik P., Hanahan D. A. Second Signal Supplied by Insulin-like Growth Factor II in Oncogene-induced Tumorigenesis. Nature 1994; 369: 414–417
   PubMed Web of Science ®Google Scholar
• Zhang L., Kashanchi F., Zhan Q., Zhan S., Brady J. N., Fornace A. J., Seth P., Helman L. J. Regulation of Insulin-like Growth Factor II P3 promoter by p53: A Potential Mechanism for Tumorigenesis. Cancer Res. 1996; 56: 1367–1373
   PubMedGoogle Scholar
• Okamoto T., Katada T., Murayama Y., Ui M., Ogata E., Nishimoto I. A Simple Structure Encodes G Protein Activating Function of the IGF-II/Mannose 6-Phosphate Receptor. Cell 1990; 62: 709–717
   PubMed Web of Science ®Google Scholar
• Okamoto T., Asano T., Harada S., Ogata E., Nishimoto. Regulation of Transmembrane Signal Transduction of Insulin-like Growth Factor II by Competence Type Growth Factors or Viral Ras p21. J. Biol. Chem. 1991; 266: 1085–1091
   PubMed Web of Science ®Google Scholar
• Dennis P. A., Rifkin D. B. Cellular Activation of Latent Transforming Growth Factor β Requires Binding to the Cation-independent Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor. Proc. Natl. Acad. Sci. 1991; 88: 580–584
   PubMed Web of Science ®Google Scholar
• Kornfeld S. Structure and Function of the Mannose 6-Phosphate/Insulin-like Growth Factor II Receptors. Annu. Rev. Biochem. 1992; 61: 307–330
   PubMed Web of Science ®Google Scholar
• Ouyang H., Shiwaku H. O., Hagiwara H., Miura K., Abe T., Kato Y., Ohtani H., Shiiba K., Sonza R. F., Meltzer S. J., Horii A. The Insulin-like Growth Factor II Receptor Gene Is Mutated in Genetically Unstable Cancers of the Endometrium, Stomach and Colorectum. Cancer Res. 1997; 57: 1851–1854
   PubMed Web of Science ®Google Scholar
• Wang S., Souza R. F., Kong D., Yin J., Smolinski K. N., Zou T. T., Frank T., Young J., Flanders K. C., Sugimura H., Abraham J. M., Meltzer S. J. Deficient Transforming Growth Factor-β1 Activation and Excessive Insulin-like Growth Factor II Expression in IGF-II Receptor Mutant Tumors. Cancer Res. 1997; 57: 2543–2546
   PubMed Web of Science ®Google Scholar